about
Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumorEarly T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumorsNitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T CellsTargeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic miceTumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation.Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment.Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2.Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo.Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma.Crucial role of inflammatory monocytes in antitumor immunityChemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation.Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells.IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK CellsIL-18 Induces PD-1-Dependent Immunosuppression in CancerDacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma LesionsCrucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivoKinetics of the response of naive and memory CD8 T cells to antigen: similarities and differencesDistinct role for CD8 T cells toward cutaneous tumors and visceral metastasesProgressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytesThe Composition of Circulating Leukocytes Varies With Age and Melanoma Onset in the MeLiM Pig Biomedical ModelEmerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous MelanomaInflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanomaThe IL4I1 Enzyme: A New Player in the Immunosuppressive Tumor MicroenvironmentSustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
P50
Q27320784-270824CA-D8AD-4EED-89C2-F69338DCF58FQ27350034-FAC9B9B7-88B5-4381-93CA-7F022C03BCA4Q28553169-28C91E08-31A0-4F5E-B3F7-EB6282447895Q33614407-EB7C7CDD-7A4B-4F25-A51A-55DA645944B4Q33882930-1C032402-AFFB-4D31-9506-7CA49A9D29C9Q35067933-5DE41C7F-5615-4751-8139-F6E02DA4B5A5Q35507024-9A78D85A-FFB1-47A6-879F-17928BB71AFCQ37012718-CD7ADDB3-A9BA-48A8-8854-ACF7B7B505A8Q37088617-6050929B-A44C-4F41-A7D0-159D5E99C54FQ37718449-EC49B964-4308-4F00-9920-97CB9B06C564Q39403897-5A7717AB-7F17-4665-AA27-2FF685E19682Q39724582-A58DFA2C-A038-49D9-AD70-B3BDA1350629Q40749248-60F5C5E7-A772-4FBA-9DF5-AA923D20F82FQ40994227-889C96C8-EF46-4DFC-AF25-6E13ABB3CE0BQ42796239-428D8BC9-A5A8-4D2C-9A93-3A6EBA05DE62Q43665853-A2F35938-A12C-4E8F-B8ED-14E36277BE2DQ47232424-DE501D00-69ED-4434-B2DF-162A1EE40E8FQ51029564-E009B083-8D6C-4C0D-BDA3-DF69361F24AAQ53881415-FC9980BE-586A-45E9-B10A-5DAD852B024FQ57556316-29F959BB-2DB1-47ED-B7CB-E0602DCEA84FQ57556330-D7A99F59-59F3-451A-8B9C-3F7B335F79ACQ58621119-3941B248-581C-4972-98B2-974742BC7644Q64898418-3617440F-7239-4BA2-B704-9494427A1D7CQ77186082-3C2C4BBD-252A-4242-8329-69CA576072B4Q77952319-3F484058-A5FB-4E82-8E69-88E1EF31B214Q80241859-0C39C983-B916-4051-8603-9EBDF4046E21Q83467024-E25C01B5-0878-4243-85DB-11D13F203D9DQ90379866-350356AF-F2F4-4BC2-88EF-DE646DF41BA5Q90502502-18919351-849F-45E2-A429-025F4F42A559Q91523937-3876F4D6-9ADA-48C8-ACF1-79DF19BE1F91Q92081780-D382C6C8-2227-4672-BF7A-709C1338F242Q93087267-E016E7DD-7C1A-4BB0-99C3-EE0CBB34A987
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Armelle Prévost-Blondel
@ast
Armelle Prévost-Blondel
@en
Armelle Prévost-Blondel
@es
Armelle Prévost-Blondel
@nl
type
label
Armelle Prévost-Blondel
@ast
Armelle Prévost-Blondel
@en
Armelle Prévost-Blondel
@es
Armelle Prévost-Blondel
@nl
prefLabel
Armelle Prévost-Blondel
@ast
Armelle Prévost-Blondel
@en
Armelle Prévost-Blondel
@es
Armelle Prévost-Blondel
@nl
P106
P1153
6602308213
P31
P496
0000-0002-7268-5905